Company page
Lixte Biotechnology Holdings, Inc.
Lixte Biotechnology Holdings, Inc. is a public company traded under the ticker LIXT in the American market. The company has a market capitalization of approximately $107.6 million. Lixte focuses on developing innovative cancer therapies and is committed to advancing its research and development efforts.
- Ticker
- LIXT:NASDAQ
- Asset type
- Stock
- Market cap
- $107.6M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- NASDAQ
- Currency
- USD